SCHEMBL7596476

SCHEMBL7596476

c1ccc(-c2ccc(N(c3ccc(-c4ccc5ccccc5c4)cc3)c3ccc(-c4cccc5ccccc45)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
ESR1 P03372 2/20 0.42
ESR2 Q92731 2/20 0.42
PPARG P37231 7/20 0.42
PPARA Q07869 7/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PPARD Q03181 1/20 0.42
MCL1 Q07820 1/20 0.41
ACMSD Q8TDX5 1/20 0.41
PIM1 P11309 1/20 0.41
TNF P01375 1/20 0.41
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
CHRNB4 P30926 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25098592 1.00 CA12 (0.50) CA12CA1CA2CA9HSD17B1
SCHEMBL26759912 1.00 CA12 (0.50) CA12CA1CA2CA9HSD17B1
SCHEMBL7590226 1.00 CA12 (0.50) CA12CA1CA2CA9HSD17B1
SCHEMBL7591698 1.00 CA12 (0.50) CA12CA1CA2CA9HSD17B1
SCHEMBL17933030 1.00 CA12 (0.50) CA12CA1CA2CA9HSD17B1
SCHEMBL7590384 0.98 CA12 (0.49) CA12CA1CA2CA9HSD17B1
SCHEMBL7596486 0.98 CA12 (0.49) CA12CA1CA2CA9HSD17B1
SCHEMBL7592740 0.98 CA12 (0.49) CA12CA1CA2CA9HSD17B1
SCHEMBL19269569 0.97 CA12 (0.48) CA12CA1CA2CA9HSD17B1
SCHEMBL7596500 0.97 CA12 (0.47) CA12CA1CA2CA9HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301178-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-21 US disclosed
US-20230301178-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-09-21 US disclosed
US-11678568-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2023-06-13 US disclosed
US-11678568-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2023-06-13 US disclosed
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LG DISPLAY CO., LTD. (KR) 2022-10-11 US disclosed
US-20210036226-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-02-04 US disclosed
US-10804471-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-10-13 US disclosed
US-20170117470-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed
US-20170117470-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed
US-9540315-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-01-10 US disclosed
US-20150141697-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-05-21 US disclosed
US-8940416-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-01-27 US disclosed
US-8940416-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-01-27 US disclosed
US-20120223298-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-09-06 US disclosed
US-20120223298-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-09-06 US disclosed
US-8182933-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
US-8182933-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
WO-2009139358-A1 TRIARYLAMINE DERIVATIVE, LIGHT-EMITTING SUBSTANCE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-11-19 WO disclosed
US-20090284140-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-11-19 US disclosed
US-20090284140-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141697-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LEF1, CLCN2, PIEZO1 CA12 830/4885CA1 989/4885CA2 799/4885
US-20230301178-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20210036226-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20090284140-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20120223298-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-11678568-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-20170117470-A1 Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885
US-10804471-B2 Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device AHR, NAT1, TAAR1 CA12 4675/4885CA1 4716/4885CA2 4718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.